Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.

Source:http://linkedlifedata.com/resource/pubmed/id/12209976

Int. J. Cancer 2002 Sep 20 101 3 253-8

Download in:

View as

General Info

PMID
12209976